+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention



Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention



American Journal of Nephrology 11(6): 441-446



In patients with congestive heart failure (CHF), the role of aldosterone in the abnormal sodium (Na+) retention and the determinants of plasma aldosterone (PA) including plasma atrial natriuretic factor (hANF), plasma renin activity (PRA), and plasma potassium (K+) have not been fully elucidated. We therefore studied the effect of the specific aldosterone antagonist, spironolactone, on urinary Na+ and K+ excretion and plasma hormone responses in 6 Na(+)-retaining CHF patients. After withdrawal of diuretics 4 days prior to the study, the CHF patients were placed on a Na+ intake of 100 mmol/day for 9 days. Spironolactone, 200 mg p.o. bid, was administered for the last 4 days of the 9-day study period. PRA and norepinephrine increased with spironolactone treatment (both p less than 0.05). Plasma hANF before spironolactone was significantly elevated and decreased during spironolactone therapy (p less than 0.05). Urinary Na+ excretion significantly increased during spironolactone administration and the positive Na+ balance was reversed in the CHF patients. Moreover, the urine Na+:K+ concentration ratio significantly increased during spironolactone administration. Analysis of the relationship between PA, plasma K+, PRA, and plasma hANF indicated that PRA is the primary determinant of PA in patients with CHF. Thus, the present results indicate that the renin-angiotensin-aldosterone system is an important mediator of Na+ retention in CHF, as evidenced by the reversal of the positive Na+ balance with a specific aldosterone antagonist. This natriuretic effect can be demonstrated in the presence of potential antinatriuretic influences including stimulation of the renin-angiotensin and sympathetic nervous systems and a decrease in plasma hANF.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 006996659

Download citation: RISBibTeXText

PMID: 1840232

DOI: 10.1159/000168356


Related references

Symposium on pathophysiology of congestive heart failure. 5. Role of the kidney in sodium retention in cardiac failure. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 62(12): 1633-1637, 1973

Role of the renal nerves in the sodium retention of congestive heart failure. Federation Proceedings 46(4): 1235, 1987

Sodium and water retention in congestive heart failure--the pivotal role of the kidney. American Journal of Hypertension 1(4 Pt 2): 395s-401s, 1988

Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. American Journal of Physiology 260(2 Pt 2): R298-R305, 1991

Mechanisms of salt and water retention in congestive heart failure. The importance of aldosterone. American Journal of Medicine 29: 486-507, 1960

Symposium on pathophysiology of congestive heart failure. 1. Relationship of renin-angiotensin-aldosterone system to cardio-renal hemodynamics on chronic congestive heart failure. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 62(12): 1609-1614, 1973

Role of aldosterone in congestive heart failure. Nihon Rinsho. Japanese Journal of Clinical Medicine 24(7): 1322-1338, 1966

Comparison of sodium depletion or repletion effects on aldosterone and sodium/potassium excretion characteristics in patients with moderate to severe congestive heart failure, in the absence of diuretics. Journal of the American College of Cardiology 0(SPEC ISSUE): 178A, 1995

The pathogenesis of sodium retention in congestive heart failure. Metabolism: Clinical and Experimental 5(4): 480-489, 1956

The role of aldosterone in the pathogenesis of congestive heart failure. Japanese Heart Journal 8(3): 252-263, 1967

Diuretic treatment for the sodium retention of congestive heart failure. Archives of Internal Medicine 154(17): 1905-1914, 1994

Sodium and water retention in chronic congestive heart failure. Journal of Chronic Diseases 9(5): 536-553, 1959

Pathogenesis of renal sodium retention in congestive heart failure. Mineral and Electrolyte Metabolism 25(1-2): 11-20, 1999

Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment. American Journal of Cardiology 59(8): 906-910, 1987

The role of aldosterone-antagonists in the treatment of congestive heart failure. Orvosi Hetilap 146(14): 645-648, 2005